Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology
To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multipar...
        Saved in:
      
    
          | Published in | Clinical & experimental metastasis Vol. 39; no. 3; pp. 479 - 493 | 
|---|---|
| Main Authors | , , , , , , , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Dordrecht
          Springer Netherlands
    
        01.06.2022
     Springer Nature B.V  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0262-0898 1573-7276 1573-7276  | 
| DOI | 10.1007/s10585-022-10155-w | 
Cover
| Abstract | To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (
p
 < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics. | 
    
|---|---|
| AbstractList | To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics.To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics. To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics. To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain ( p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics.  | 
    
| Author | Soete, Jeroen Chen, Lei De Keyzer, Frederik Ni, Yicheng Van Ongeval, Chantal Wang, Shuncong Yin, Ting Wevers, Martine Peeters, Ronald Li, Yue Yu, Jie Swinnen, Johan Feng, Yuanbo Bormans, Guy  | 
    
| Author_xml | – sequence: 1 givenname: Shuncong orcidid: 0000-0003-0656-2760 surname: Wang fullname: Wang, Shuncong organization: KU Leuven, Biomedical Group, Campus Gasthuisberg – sequence: 2 givenname: Lei surname: Chen fullname: Chen, Lei organization: KU Leuven, Biomedical Group, Campus Gasthuisberg – sequence: 3 givenname: Yuanbo surname: Feng fullname: Feng, Yuanbo organization: KU Leuven, Biomedical Group, Campus Gasthuisberg – sequence: 4 givenname: Ting surname: Yin fullname: Yin, Ting organization: KU Leuven, Biomedical Group, Campus Gasthuisberg, MR Collaborations, Siemens Healthineers Ltd – sequence: 5 givenname: Jie surname: Yu fullname: Yu, Jie organization: KU Leuven, Biomedical Group, Campus Gasthuisberg – sequence: 6 givenname: Frederik surname: De Keyzer fullname: De Keyzer, Frederik organization: Department of Radiology, University Hospitals Leuven – sequence: 7 givenname: Ronald surname: Peeters fullname: Peeters, Ronald organization: Department of Radiology, University Hospitals Leuven – sequence: 8 givenname: Chantal surname: Van Ongeval fullname: Van Ongeval, Chantal organization: Department of Radiology, University Hospitals Leuven – sequence: 9 givenname: Guy surname: Bormans fullname: Bormans, Guy organization: KU Leuven, Biomedical Group, Campus Gasthuisberg – sequence: 10 givenname: Johan surname: Swinnen fullname: Swinnen, Johan organization: KU Leuven, Biomedical Group, Campus Gasthuisberg – sequence: 11 givenname: Jeroen surname: Soete fullname: Soete, Jeroen organization: KU Leuven, Department of Materials Engineering – sequence: 12 givenname: Martine surname: Wevers fullname: Wevers, Martine organization: KU Leuven, Department of Materials Engineering – sequence: 13 givenname: Yue surname: Li fullname: Li, Yue email: liy_16@sumhs.edu.cn organization: KU Leuven, Biomedical Group, Campus Gasthuisberg, Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences – sequence: 14 givenname: Yicheng surname: Ni fullname: Ni, Yicheng email: yicheng.ni@kuleuven.be organization: KU Leuven, Biomedical Group, Campus Gasthuisberg, Department of Radiology, University Hospitals Leuven  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35218457$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNp9kc9u1DAQxi1URLeFF-CALHHhErCdOHaOqKWAVKmX9mx57fGuq8QOtkO1PAGPXXe3UKmHnkaa-X3z7ztBRyEGQOg9JZ8pIeJLpoRL3hDGGkoo583dK7SiXLSNYKI_QivCetYQOchjdJLzLSGkE0K-QcctZ1R2XKzQ33P4DWOcJwgF62Cx2eqkTYHk_-jiY8DRYY2TLnidtA94gqJzqSWDyzLFhKdoYcTrHZ6Wsfi5qiuSannSmwAPXIIcgw4GsK85Hzb7QVufS6wN5m0c42b3Fr12eszw7jGeopuLb9dnP5rLq-8_z75eNqYVvDTM8mEgnTZ80NbwnhAtBCVWGNa5gRLntHbAO1d_s3ZCWOgdUMYd5b1lVran6NOh75zirwVyUZPPBsZRB4hLVqxvWzlw2bKKfnyG3sYlhbpdpfqeUlZDpT48Ust6AqvmVK9MO_XvxxVgB8CkmHMC9x-hRD0YqQ5Gqmqk2hup7qpIPhMZX_aGlGrD-LK0PUhznRM2kJ7WfkF1D2H_tZk | 
    
| CitedBy_id | crossref_primary_10_1186_s40478_023_01509_w crossref_primary_10_3390_cancers14235826  | 
    
| Cites_doi | 10.7150/thno.46468 10.1158/2159-8290.CD-18-0044 10.1016/j.joca.2008.09.009 10.1038/bjc.2017.324 10.3390/jcm9010084 10.1002/mrm.21959 10.1038/s41571-019-0320-3 10.1002/ijc.31567 10.1158/0008-5472.CAN-16-2499 10.3322/caac.21492 10.1002/nbm.3676 10.4103/2152-7806.111298 10.1093/neuonc/nox077 10.1016/j.nicl.2014.09.002 10.1155/2018/7628037 10.7150/thno.5790 10.3322/caac.21590 10.1093/neuonc/noaa266 10.1016/j.neuroimage.2006.01.015 10.1038/s41416-019-0495-5 10.1148/radiol.11091882 10.1126/science.1203543 10.1016/j.jocn.2015.11.012 10.1038/srep39449 10.1186/s12885-020-06808-2 10.1186/bcr3244 10.1200/JCO.2007.12.2440 10.1007/s11912-011-0203-y 10.1038/s41598-019-45682-2 10.1016/j.trecan.2018.01.003 10.3389/fonc.2021.651137 10.1148/radiol.11102120 10.1016/j.addr.2021.114043 10.1007/s10549-014-2854-5 10.1038/s41568-019-0205-x 10.1371/journal.pone.0163521  | 
    
| ContentType | Journal Article | 
    
| Copyright | The Author(s), under exclusive licence to Springer Nature B.V. 2022 2022. The Author(s), under exclusive licence to Springer Nature B.V. The Author(s), under exclusive licence to Springer Nature B.V. 2022.  | 
    
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2022 – notice: 2022. The Author(s), under exclusive licence to Springer Nature B.V. – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2022.  | 
    
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 88I 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. M0S M1P M2P P5Z P62 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8  | 
    
| DOI | 10.1007/s10585-022-10155-w | 
    
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Computer Science Collection ProQuest Central Essentials - QC ProQuest Central Technology Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Science Database ProQuest Central Advanced Technologies & Aerospace Database (via ProQuest) ProQuest Advanced Technologies & Aerospace Collection Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Collection Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Central Student  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1573-7276 | 
    
| EndPage | 493 | 
    
| ExternalDocumentID | 35218457 10_1007_s10585_022_10155_w  | 
    
| Genre | Journal Article | 
    
| GroupedDBID | --- -4W -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5C9 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 88I 8FE 8FG 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGLVJ BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LK5 LLZTM M1P M2P M4Y M7R MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P62 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBY SCLPG SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS Q9U 7X8  | 
    
| ID | FETCH-LOGICAL-c375t-2d59904ac59adc5600a7710d7c24f910ffaafe54f105bf77de6fe125f156d2d83 | 
    
| IEDL.DBID | U2A | 
    
| ISSN | 0262-0898 1573-7276  | 
    
| IngestDate | Thu Sep 04 20:05:49 EDT 2025 Fri Oct 03 07:12:23 EDT 2025 Tue Sep 30 00:37:09 EDT 2025 Thu Apr 24 23:02:04 EDT 2025 Wed Oct 01 03:48:12 EDT 2025 Fri Feb 21 02:45:32 EST 2025  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 3 | 
    
| Keywords | Magnetic resonance imaging (MRI) VDA Rodent Brain metastasis (BM) Disease model  | 
    
| Language | English | 
    
| License | 2022. The Author(s), under exclusive licence to Springer Nature B.V. | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c375t-2d59904ac59adc5600a7710d7c24f910ffaafe54f105bf77de6fe125f156d2d83 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
    
| ORCID | 0000-0003-0656-2760 | 
    
| PMID | 35218457 | 
    
| PQID | 2666112266 | 
    
| PQPubID | 30909 | 
    
| PageCount | 15 | 
    
| ParticipantIDs | proquest_miscellaneous_2633895832 proquest_journals_2666112266 pubmed_primary_35218457 crossref_primary_10_1007_s10585_022_10155_w crossref_citationtrail_10_1007_s10585_022_10155_w springer_journals_10_1007_s10585_022_10155_w  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2022-06-01 | 
    
| PublicationDateYYYYMMDD | 2022-06-01 | 
    
| PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01  | 
    
| PublicationDecade | 2020 | 
    
| PublicationPlace | Dordrecht | 
    
| PublicationPlace_xml | – name: Dordrecht – name: Netherlands  | 
    
| PublicationSubtitle | Official Journal of the Metastasis Research Society | 
    
| PublicationTitle | Clinical & experimental metastasis | 
    
| PublicationTitleAbbrev | Clin Exp Metastasis | 
    
| PublicationTitleAlternate | Clin Exp Metastasis | 
    
| PublicationYear | 2022 | 
    
| Publisher | Springer Netherlands Springer Nature B.V  | 
    
| Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V  | 
    
| References | Bontempi (CR33) 2021; 11 Siegel, Miller, Jemal (CR2) 2020; 70 Yushkevich (CR22) 2006; 31 Duchnowska (CR9) 2012; 14 Genovesi (CR18) 2021; 23 Li (CR16) 2013; 3 Fink, Fink (CR31) 2013; 4 McGrath (CR24) 2009; 61 Abma (CR17) 2019; 9 Suh (CR7) 2020; 17 Schoen (CR37) 2021; 180 Li (CR15) 2011; 260 Yin (CR23) 2017; 30 Yao (CR27) 2018; 2018 Brighi (CR29) 2020; 10 Castets (CR32) 2016; 6 Shah (CR10) 2020; 20 Ordovas, Higgins (CR35) 2011; 261 Brower (CR6) 2016; 27 Teleanu (CR11) 2019; 9 Puchalapalli (CR38) 2016; 11 CR25 Shi (CR14) 2017; 77 Bray (CR1) 2018; 68 CR21 Cagney (CR4) 2017; 19 Chaffer, Weinberg (CR3) 2011; 331 Arvanitis, Ferraro, Jain (CR19) 2020; 20 Heye (CR20) 2014; 6 Chou (CR34) 2009; 17 Nayak, Lee, Wen (CR5) 2012; 14 Vredenburgh (CR12) 2007; 25 Liu (CR13) 2018; 143 Yin (CR36) 2017; 117 Ireson (CR28) 2019; 121 Olson (CR30) 2018; 8 Valiente (CR8) 2018; 4 Do (CR26) 2014; 144 RI Teleanu (10155_CR11) 2019; 9 AK Heye (10155_CR20) 2014; 6 P Bontempi (10155_CR33) 2021; 11 10155_CR21 C Shi (10155_CR14) 2017; 77 CL Chaffer (10155_CR3) 2011; 331 PA Yushkevich (10155_CR22) 2006; 31 L Yao (10155_CR27) 2018; 2018 10155_CR25 MC Chou (10155_CR34) 2009; 17 J Li (10155_CR16) 2013; 3 J Do (10155_CR26) 2014; 144 B Olson (10155_CR30) 2018; 8 L Nayak (10155_CR5) 2012; 14 M Valiente (10155_CR8) 2018; 4 T Yin (10155_CR36) 2017; 117 CR Castets (10155_CR32) 2016; 6 KG Ordovas (10155_CR35) 2011; 261 CD Arvanitis (10155_CR19) 2020; 20 JH Suh (10155_CR7) 2020; 17 Y Liu (10155_CR13) 2018; 143 F Bray (10155_CR1) 2018; 68 J Li (10155_CR15) 2011; 260 T Yin (10155_CR23) 2017; 30 C Brighi (10155_CR29) 2020; 10 RL Siegel (10155_CR2) 2020; 70 KR Fink (10155_CR31) 2013; 4 R Duchnowska (10155_CR9) 2012; 14 N Shah (10155_CR10) 2020; 20 JJ Vredenburgh (10155_CR12) 2007; 25 CR Ireson (10155_CR28) 2019; 121 LA Genovesi (10155_CR18) 2021; 23 DN Cagney (10155_CR4) 2017; 19 JV Brower (10155_CR6) 2016; 27 DM McGrath (10155_CR24) 2009; 61 S Schoen Jr (10155_CR37) 2021; 180 M Puchalapalli (10155_CR38) 2016; 11 E Abma (10155_CR17) 2019; 9  | 
    
| References_xml | – volume: 10 start-page: 6361 issue: 14 year: 2020 end-page: 6371 ident: CR29 article-title: Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity publication-title: Theranostics doi: 10.7150/thno.46468 – volume: 8 start-page: 1358 issue: 11 year: 2018 end-page: 1365 ident: CR30 article-title: Mouse models for cancer immunotherapy research publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-18-0044 – volume: 17 start-page: 441 issue: 4 year: 2009 end-page: 447 ident: CR34 article-title: Correlation between the MR T2 value at 47 T and relative water content in articular cartilage in experimental osteoarthritis induced by ACL transection publication-title: Osteoarthritis Cartilage doi: 10.1016/j.joca.2008.09.009 – volume: 117 start-page: 1529 issue: 10 year: 2017 end-page: 1536 ident: CR36 article-title: Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology publication-title: Br J Cancer doi: 10.1038/bjc.2017.324 – volume: 9 start-page: 84 issue: 1 year: 2019 ident: CR11 article-title: Tumor angiogenesis and anti-angiogenic strategies for cancer treatment publication-title: J Clin Med doi: 10.3390/jcm9010084 – volume: 61 start-page: 1173 issue: 5 year: 2009 end-page: 1184 ident: CR24 article-title: Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats publication-title: Magn Reson Med doi: 10.1002/mrm.21959 – volume: 17 start-page: 279 issue: 5 year: 2020 end-page: 299 ident: CR7 article-title: Current approaches to the management of brain metastases publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-019-0320-3 – volume: 143 start-page: 1817 issue: 7 year: 2018 end-page: 1828 ident: CR13 article-title: The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats publication-title: Int J Cancer doi: 10.1002/ijc.31567 – volume: 77 start-page: 3491 issue: 13 year: 2017 ident: CR14 article-title: Monitoring Tumor response to antivascular therapy using non-contrast intravoxel incoherent motion diffusion-weighted MRI publication-title: Can Res doi: 10.1158/0008-5472.CAN-16-2499 – volume: 68 start-page: 394 issue: 6 year: 2018 end-page: 424 ident: CR1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 30 start-page: 3676 issue: 2 year: 2017 ident: CR23 article-title: Characterization of a rat orthotopic pancreatic head tumor model using three-dimensional and quantitative multi-parametric MRI publication-title: NMR Biomed doi: 10.1002/nbm.3676 – volume: 4 start-page: S209 issue: 4 year: 2013 end-page: S219 ident: CR31 article-title: Imaging of brain metastases publication-title: Surg Neurol Int doi: 10.4103/2152-7806.111298 – volume: 19 start-page: 1511 issue: 11 year: 2017 end-page: 1521 ident: CR4 article-title: Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study publication-title: Neuro Oncol doi: 10.1093/neuonc/nox077 – volume: 6 start-page: 262 year: 2014 end-page: 274 ident: CR20 article-title: Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI publication-title: A systematic review Neuroimage Clin doi: 10.1016/j.nicl.2014.09.002 – ident: CR25 – volume: 2018 start-page: 7628037 year: 2018 ident: CR27 article-title: Evans Blue Dye: A Revisit of Its Applications in Biomedicine publication-title: Contrast Media Mol Imaging doi: 10.1155/2018/7628037 – volume: 3 start-page: 127 issue: 2 year: 2013 end-page: 137 ident: CR16 article-title: Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts publication-title: Theranostics doi: 10.7150/thno.5790 – volume: 70 start-page: 7 issue: 1 year: 2020 end-page: 30 ident: CR2 article-title: Cancer statistics publication-title: CA A Cancer J Clin doi: 10.3322/caac.21590 – volume: 23 start-page: 732 issue: 5 year: 2021 end-page: 742 ident: CR18 article-title: Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier publication-title: Neuro Oncol doi: 10.1093/neuonc/noaa266 – volume: 31 start-page: 1116 issue: 3 year: 2006 end-page: 1128 ident: CR22 article-title: User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability publication-title: Neuroimage doi: 10.1016/j.neuroimage.2006.01.015 – volume: 121 start-page: 101 issue: 2 year: 2019 end-page: 108 ident: CR28 article-title: The role of mouse tumour models in the discovery and development of anticancer drugs publication-title: British J Cancer doi: 10.1038/s41416-019-0495-5 – volume: 261 start-page: 358 issue: 2 year: 2011 end-page: 374 ident: CR35 article-title: Delayed contrast enhancement on MR images of myocardium: past, present Future publication-title: Radiology doi: 10.1148/radiol.11091882 – volume: 331 start-page: 1559 year: 2011 end-page: 1564 ident: CR3 article-title: A perspective on cancer cell metastasis publication-title: Science doi: 10.1126/science.1203543 – ident: CR21 – volume: 27 start-page: 130 year: 2016 end-page: 137 ident: CR6 article-title: Management of leptomeningeal metastases: Prognostic factors and associated outcomes publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2015.11.012 – volume: 6 start-page: 39449 issue: 1 year: 2016 ident: CR32 article-title: In vivo MEMRI characterization of brain metastases using a 3D Look-Locker T1-mapping sequence publication-title: Sci Rep doi: 10.1038/srep39449 – volume: 20 start-page: 292 issue: 1 year: 2020 ident: CR10 article-title: Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis publication-title: BMC Cancer doi: 10.1186/s12885-020-06808-2 – volume: 14 start-page: R119 issue: 4 year: 2012 ident: CR9 article-title: Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain publication-title: Breast Cancer Res doi: 10.1186/bcr3244 – volume: 25 start-page: 4722 issue: 30 year: 2007 end-page: 4729 ident: CR12 article-title: Bevacizumab plus irinotecan in recurrent glioblastoma multiforme publication-title: J Clin Oncol doi: 10.1200/JCO.2007.12.2440 – volume: 14 start-page: 48 issue: 1 year: 2012 end-page: 54 ident: CR5 article-title: Epidemiology of brain metastases publication-title: Curr Oncol Rep doi: 10.1007/s11912-011-0203-y – volume: 9 start-page: 9262 issue: 1 year: 2019 ident: CR17 article-title: Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients publication-title: Sci Rep doi: 10.1038/s41598-019-45682-2 – volume: 4 start-page: 176 issue: 3 year: 2018 end-page: 196 ident: CR8 article-title: The Evolving Landscape of Brain Metastasis publication-title: Trends Cancer doi: 10.1016/j.trecan.2018.01.003 – volume: 11 start-page: 834 year: 2021 ident: CR33 article-title: Quantitative multicomponent T2 relaxation showed greater sensitivity than flair imaging to detect subtle alterations at the periphery of lower grade gliomas publication-title: Front Oncol doi: 10.3389/fonc.2021.651137 – volume: 260 start-page: 799 issue: 3 year: 2011 end-page: 807 ident: CR15 article-title: A dual-targeting anticancer approach: soil and seed principle publication-title: Radiology doi: 10.1148/radiol.11102120 – volume: 180 start-page: 114043 year: 2021 ident: CR37 article-title: Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2021.114043 – volume: 144 start-page: 93 issue: 1 year: 2014 end-page: 101 ident: CR26 article-title: Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-2854-5 – volume: 20 start-page: 26 issue: 1 year: 2020 end-page: 41 ident: CR19 article-title: The blood–brain barrier and blood–tumour barrier in brain tumours and metastases publication-title: Nat Rev Cancer doi: 10.1038/s41568-019-0205-x – volume: 11 start-page: e0163521 issue: 9 year: 2016 ident: CR38 article-title: NSG mice provide a better spontaneous model of breast cancer metastasis than athymic (Nude) Mice publication-title: PLoS ONE doi: 10.1371/journal.pone.0163521 – volume: 77 start-page: 3491 issue: 13 year: 2017 ident: 10155_CR14 publication-title: Can Res doi: 10.1158/0008-5472.CAN-16-2499 – volume: 11 start-page: e0163521 issue: 9 year: 2016 ident: 10155_CR38 publication-title: PLoS ONE doi: 10.1371/journal.pone.0163521 – volume: 144 start-page: 93 issue: 1 year: 2014 ident: 10155_CR26 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-2854-5 – volume: 8 start-page: 1358 issue: 11 year: 2018 ident: 10155_CR30 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-18-0044 – volume: 17 start-page: 441 issue: 4 year: 2009 ident: 10155_CR34 publication-title: Osteoarthritis Cartilage doi: 10.1016/j.joca.2008.09.009 – volume: 143 start-page: 1817 issue: 7 year: 2018 ident: 10155_CR13 publication-title: Int J Cancer doi: 10.1002/ijc.31567 – volume: 9 start-page: 84 issue: 1 year: 2019 ident: 10155_CR11 publication-title: J Clin Med doi: 10.3390/jcm9010084 – volume: 19 start-page: 1511 issue: 11 year: 2017 ident: 10155_CR4 publication-title: Neuro Oncol doi: 10.1093/neuonc/nox077 – volume: 27 start-page: 130 year: 2016 ident: 10155_CR6 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2015.11.012 – volume: 20 start-page: 26 issue: 1 year: 2020 ident: 10155_CR19 publication-title: Nat Rev Cancer doi: 10.1038/s41568-019-0205-x – volume: 6 start-page: 262 year: 2014 ident: 10155_CR20 publication-title: A systematic review Neuroimage Clin doi: 10.1016/j.nicl.2014.09.002 – volume: 20 start-page: 292 issue: 1 year: 2020 ident: 10155_CR10 publication-title: BMC Cancer doi: 10.1186/s12885-020-06808-2 – volume: 31 start-page: 1116 issue: 3 year: 2006 ident: 10155_CR22 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2006.01.015 – volume: 117 start-page: 1529 issue: 10 year: 2017 ident: 10155_CR36 publication-title: Br J Cancer doi: 10.1038/bjc.2017.324 – volume: 121 start-page: 101 issue: 2 year: 2019 ident: 10155_CR28 publication-title: British J Cancer doi: 10.1038/s41416-019-0495-5 – volume: 180 start-page: 114043 year: 2021 ident: 10155_CR37 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2021.114043 – volume: 10 start-page: 6361 issue: 14 year: 2020 ident: 10155_CR29 publication-title: Theranostics doi: 10.7150/thno.46468 – volume: 331 start-page: 1559 year: 2011 ident: 10155_CR3 publication-title: Science doi: 10.1126/science.1203543 – volume: 4 start-page: 176 issue: 3 year: 2018 ident: 10155_CR8 publication-title: Trends Cancer doi: 10.1016/j.trecan.2018.01.003 – volume: 25 start-page: 4722 issue: 30 year: 2007 ident: 10155_CR12 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.12.2440 – volume: 17 start-page: 279 issue: 5 year: 2020 ident: 10155_CR7 publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-019-0320-3 – volume: 9 start-page: 9262 issue: 1 year: 2019 ident: 10155_CR17 publication-title: Sci Rep doi: 10.1038/s41598-019-45682-2 – volume: 30 start-page: 3676 issue: 2 year: 2017 ident: 10155_CR23 publication-title: NMR Biomed doi: 10.1002/nbm.3676 – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 10155_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 70 start-page: 7 issue: 1 year: 2020 ident: 10155_CR2 publication-title: CA A Cancer J Clin doi: 10.3322/caac.21590 – volume: 4 start-page: S209 issue: 4 year: 2013 ident: 10155_CR31 publication-title: Surg Neurol Int doi: 10.4103/2152-7806.111298 – volume: 6 start-page: 39449 issue: 1 year: 2016 ident: 10155_CR32 publication-title: Sci Rep doi: 10.1038/srep39449 – volume: 11 start-page: 834 year: 2021 ident: 10155_CR33 publication-title: Front Oncol doi: 10.3389/fonc.2021.651137 – volume: 14 start-page: 48 issue: 1 year: 2012 ident: 10155_CR5 publication-title: Curr Oncol Rep doi: 10.1007/s11912-011-0203-y – ident: 10155_CR21 – ident: 10155_CR25 – volume: 61 start-page: 1173 issue: 5 year: 2009 ident: 10155_CR24 publication-title: Magn Reson Med doi: 10.1002/mrm.21959 – volume: 260 start-page: 799 issue: 3 year: 2011 ident: 10155_CR15 publication-title: Radiology doi: 10.1148/radiol.11102120 – volume: 2018 start-page: 7628037 year: 2018 ident: 10155_CR27 publication-title: Contrast Media Mol Imaging doi: 10.1155/2018/7628037 – volume: 23 start-page: 732 issue: 5 year: 2021 ident: 10155_CR18 publication-title: Neuro Oncol doi: 10.1093/neuonc/noaa266 – volume: 3 start-page: 127 issue: 2 year: 2013 ident: 10155_CR16 publication-title: Theranostics doi: 10.7150/thno.5790 – volume: 261 start-page: 358 issue: 2 year: 2011 ident: 10155_CR35 publication-title: Radiology doi: 10.1148/radiol.11091882 – volume: 14 start-page: R119 issue: 4 year: 2012 ident: 10155_CR9 publication-title: Breast Cancer Res doi: 10.1186/bcr3244  | 
    
| SSID | ssj0004778 | 
    
| Score | 2.372591 | 
    
| Snippet | To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed.... | 
    
| SourceID | proquest pubmed crossref springer  | 
    
| SourceType | Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 479 | 
    
| SubjectTerms | Angiography Animal models Animals Biomedical and Life Sciences Biomedicine Brain Brain cancer Brain Neoplasms - diagnostic imaging Brain tumors Cancer Research Contrast agents Diffusion coefficient Diffusion Magnetic Resonance Imaging Digital imaging Female Functional magnetic resonance imaging Hematology Histopathology Humans Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Medical imaging Metastases Metastasis Multiparametric Magnetic Resonance Imaging Necrosis Neuroimaging Oncology Perfusion Radiography Rats Research Paper Rhabdomyosarcoma Surgical Oncology Translation Tumors  | 
    
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7SDZReSpq-nKRFhd5a0Vq2LO-hlDYkhECWUhrIzehZAl17m3gJ-Qf52ZmR5d2G0Jx8sCwZzWj0STPzDcD7XItQexG4KnXNS-8trwtjuS7zIIwubC4o3_lkVh2dlsdn8mwDZmMuDIVVjjYxGmrXWboj_4QbSYXYAB9fF385VY0i7-pYQkOn0gruS6QYewSbgpixJrD5_WD24-c6U1INtllUgn-up3VKo0nJdAidOUW35wQk-NXdreoe_rznO41b0uEWPE1Ykn0bhP8MNny7DY9Pkrf8Odz8ExHEdOuYXbEzD8mXrAtMM9QBZqhSBJv7XlOG0bll_XLeXbBYJ4eZazbEHWqK5CJKfzbXv1tKf2R4Wu-Is8Oz83kseBQHiizG2MEi2tbrF3B6ePBr_4inygvcFkr2XDiJu1SprZxqZwkUaYVQxCkryoAAIwStg5dlwDkzQSnnq-ARKgU8DTrh6uIlTNqu9a-BySoIwkhC5aYUNjfKYdvCS-cNcd1nkI-T3NhES07VMf40a0JlEkyDgmmiYJqrDD6svlkMpBwPtt4bZdekBXrZrNUpg3er17i0yF-iW98tqQ2e36cSbV4GrwaZr4ZD3IpnY6ky-Dgqwbrz___LzsP_sgtPBClgvOXZg0l_sfRvEPT05m3S5FsvQwBW priority: 102 providerName: ProQuest  | 
    
| Title | Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology | 
    
| URI | https://link.springer.com/article/10.1007/s10585-022-10155-w https://www.ncbi.nlm.nih.gov/pubmed/35218457 https://www.proquest.com/docview/2666112266 https://www.proquest.com/docview/2633895832  | 
    
| Volume | 39 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1573-7276 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004778 issn: 0262-0898 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 1573-7276 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0004778 issn: 0262-0898 databaseCode: 8FG dateStart: 19990201 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1573-7276 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004778 issn: 0262-0898 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1573-7276 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004778 issn: 0262-0898 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9sC-KL-G20Hiv4pgtmk83mHu_krkXpIeLB-RT2UwpeUtocpf9B_-zObJK7SlXwJfuQySbs7M78NjvzG4B3qRah9CJwleuS595bXmbGcp2nQRid2VRQvvPJojhe5p9XctUnhV0M0e7DkWS01LeS3RDacoo-T8nR88s9OJBE54WzeCkmu2xI1dlfUQj-sRyXfarMn_v43R3dwZh3zkej25k_goc9XmSTTsGP4Z6vn8D9k_5E_Clc34r6Ybp2zG4ZmLsES9YEphnqmRmqBsHWvtWURXRqWbtZN-cs1sJh5op1sYWaorWItp-t9c-aUhwZ7sgb4uXw7HQdixrFF0WmYuzgLNrPq2ewnM--fzrmfXUFbjMlWy6cRE-UayvH2lkCPloh3HDKijwgiAhB6-BlHnDMTFDK-SJ4hEMBd3xOuDJ7Dvt1U_uXwGQRBOEgoVKTC5sa5VA289J5Q3z2CaTDIFe2px6nChi_qh1pMimmQsVUUTHVZQLvt8-cdcQb_5Q-HHRX9YvwokLsUSCcxCaBt9vbuHzoTETXvtmQDO7RxxLtWgIvOp1vX4fYFPe_UiXwYZgEu87__i2v_k_8NTwQNCHjn51D2G_PN_4NAp3WjGBPrRRey_nRCA4m8-l0Qe3Rjy8zbKezxddvozj3bwAvzv2k | 
    
| linkProvider | Springer Nature | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVgIuiDeGAosEJ1iB12uvc6gQj1YpbSKEWqk3d70PVInYIXUU5R_wq_htzKztBFTRW085ZLO2MuOZb7zzzQfwMtbC5054rqTOuXTO8DwpDdcy9qLUiYkF8Z1H42x4LL-cpCcb8LvnwlBbZR8TQ6C2taF35G8xkWSIDfDj_fQnJ9UoOl3tJTR0J61gd8KIsY7YceCWCyzhznf2P6O9Xwmxt3v0acg7lQFuEpU2XNgUI7LUJh1oawgAaIVp1yojpMdk6r3W3qXSIxIpvVLWZd4hLPBY-Vhh8wT3vQZbMpEDLP62Pu6Ov35bMzNVmwtEJvi7fJB3tJ2OvIdQnVM3fUzAhS_-TY0X8O6Fs9qQAvduw60Ou7IPrbPdgQ1X3YXro-50_h78-qsDienKMrOaBt2SPVntmWboc6wkZQo2cY0mRtOZYc18Us9Y0OVh5ZK1fY6aOsdIQoBN9PeK6JZs5qh2QE9lZ5MgsBQuFKYm4wbTEMuX9-H4SmzwADarunKPgKWZF4TJhIpLKUxcKotrE5daV9Js_Qji_k8uTDcGndQ4fhTrAc5kmAINUwTDFIsIXq9-M22HgFy6eru3XdEFhPNi7b4RvFh9jY8ync_oytVzWpMgfEwxxkbwsLX56nKIk7EWT1UEb3onWG_-_3t5fPm9PIcbw6PRYXG4Pz54AjcFOWN4w7QNm81s7p4i4GrKZ51XMzi96gfpD4Q-Pdg | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEG8CBYwEJ7BKnDjOHhBClFVLacWBSnsLfqJKbLJss1rtP-A38euYcZJdUEVvPeUQx7Yy45lvPC-AF6kWofQicJXrkufeW15mxnKdp0EYndlUUL7z8UlxcJp_msjJFvwecmEorHKQiVFQu8bSHfkeKpICsQE-9kIfFvFlf_xu9pNTBynytA7tNDoWOfKrJZpv528P95HWL4UYf_z64YD3HQa4zZRsuXASpXGurRxpZ0n5a4Uq1ykr8oCKNAStg5d5QBRiglLOF8EjJAho9TjhygznvQbXVZaNKJxQTdQmJ1N1WkAUgr8pR2WfsNOn7SFI5xRHnxJk4ct_leIFpHvBSxuV3_gW3OxRK3vfsdlt2PL1Hdg57v3yd-HXX7FHTNeO2XUd6C7NkzWBaYbcxgz1pGBT32rKZTqzrF1MmzmLHXmYWbEuwlFTzBg1D2BT_b2mREs292Q1II-ys2lsrRQXivWScYJZlOKre3B6JRS4D9t1U_uHwGQRBKExoVKTC5sa5XBs5qXzhqrqJ5AOP7myfQF06sPxo9qUbibCVEiYKhKmWibwav3NrCv_ceno3YF2VS8KzqsN4ybwfP0aDzF5ZnTtmwWNyRA4SpSuCTzoaL5eDhEyWuFSJfB6YILN5P_fy6PL9_IMdvD4VJ8PT44eww1BvBivlnZhu50v_BNEWq15GlmawberPkN_AM3AO3I | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+characterization+of+a+rat+brain+metastatic+tumor+model+by+multiparametric+magnetic+resonance+imaging+and+histomorphology&rft.jtitle=Clinical+%26+experimental+metastasis&rft.au=Wang%2C+Shuncong&rft.au=Chen%2C+Lei&rft.au=Feng%2C+Yuanbo&rft.au=Yin%2C+Ting&rft.date=2022-06-01&rft.pub=Springer+Netherlands&rft.issn=0262-0898&rft.eissn=1573-7276&rft.volume=39&rft.issue=3&rft.spage=479&rft.epage=493&rft_id=info:doi/10.1007%2Fs10585-022-10155-w&rft.externalDocID=10_1007_s10585_022_10155_w | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0262-0898&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0262-0898&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0262-0898&client=summon |